AC Immune SA Stock News

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 16.) * BioNTech SE - ADR (NASDAQ: BNTX) (announced eff

Guardant Health (GH) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Guardant Health (GH) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

LAUSANNE, Switzerland, March 05, 2020 -- AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company, announced today that four new data presentations.

Andrea Pfeifer is the CEO of AC Immune SA (NASDAQ:ACIU). This analysis aims first to contrast CEO compensation with...

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AC Immune SA (ACIU), Autolus Therapeutics (AUTL) and

Top Ranked Momentum Stocks to Buy for January 30th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 30th.

Eli Lilly and Company (NYSE: LLY) today announced financial results for the fourth quarter and full year of 2019.

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

Hedge funds are known to underperform the bull markets but that's not because they are bad at investing. Truth be told, most hedge fund managers and other smaller players within this industry are very

LAUSANNE, Switzerland, Nov. 14, 2019 -- AC Immune SA (NASDAQ: ACIU), a Swiss-based biopharmaceutical company with a broad clinical-stage pipeline focused on neurodegenerative.

CHF 32 Million in Milestone Revenues Multiple Upcoming Catalysts Execution Across Clinical and Preclinical Neurodegenerative Development Pipeline LAUSANNE, Switzerland,.

Here we highlight five biotech companies, which are expected to deliver positive earnings surprises in this earnings season.

Favorable industrial production in the United States is likely to have favored Linde's (LIN) Q3 earnings.